Efficient and Accurate Modeling of Conformational Transitions in Proteins: The Case of c-Src Kinase by Milanetti, Edoardo et al.
Efficient and Accurate Modeling of Conformational Transitions in
Proteins: The Case of c‑Src Kinase
Edoardo Milanetti,†,‡ Alexandra G. Trandafir,§ Josephine Alba,§ Domenico Raimondo,∥
and Marco D’Abramo*,§
†Department of Physics and §Department of Chemistry, Sapienza University of Rome, P. le A. Moro, 5, 00185 Rome, Italy*
‡Center for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia, Viale Regina Elena 291, 00161 Rome, Italy
∥Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy
*S Supporting Information
ABSTRACT: The theoretical computational modeling of large conforma-
tional transitions occurring in biomolecules still represents a challenge.
Here, we present an accurate “in silico” description of the activation and
deactivation mechanisms of human c-Src kinases, a fundamental process
regulating several crucial cell functions. Our results clearly show that by
applying an efficient and automated algorithm able to drive the molecular
dynamics (MD) sampling along the pathway between the two c-Src
conformational statesthe active state and the inactive stateit is possible
to accurately describe, at reduced computational costs, the molecular
mechanism underlying these large conformational rearrangements. This
procedure, combining the MD simulations with the sampling along the well-
defined principal motions connecting the two conformational states, allows
to provide a description well beyond the present computational limits, and it
is easily applicable to different systems where the structures of both the
initial and final states are known.
1. INTRODUCTION
The Src family kinases (SFKs) are the main group of
nonreceptor tyrosine kinases. They are enzymes involved in
different regulation processes with important roles in signal
transduction following the engagement of many different
classes of cellular receptors. They control cell growth,
differentiation, migration, and cell survival, and their activity
is regulated by the phosphorylation status of two tyrosine
residues in key positions and by ligand interaction through
kinase domains. These interactions stabilize the kinase in an
active or inactive form. A dysfunction in the SFK kinase
control mechanisms can cause a change in their activation,
which is directly related to the onset of many pathologies such
as neoplastic progression,1,2 preeclampsia,3 and immune
disorders.4
The SFKs are proteins of 52−62 kDa, sharing a conserved
modular domain organization as we reported in Figure 1. The
human Src gene encodes 536 amino acids (the UniProtKB/
Swiss-Prot accession code: P1293). From the N-terminus to
the C-terminus direction, the c-Src protein is composed of an
SH3 domain, an SH2 domain, an SH2-kinase linker portion, a
protein−tyrosine kinase domain (SH1), and a C-terminal
regulatory portion (Figure 1). The c-Src kinase domain
which was investigated hereis a well-conserved protein when
we consider the SFK family proteins or other tyrosine kinases;
moreover, it is both indispensable and sufficient for enzymatic
activity. The kinase domain (residues 270−523 according to
the UniProtKB/Swiss-Prot annotation) is composed by the N-
terminal region (N-lobe) and the C-terminal region (C-lobe).
Active site includes (1) the glycine-rich loop region and C-
helix from the N-lobe and (2) the catalytic and activation loops
from the C-lobe. The enzymatic activity is regulated by the
conformational variation and three-dimensional rearrange-
ments of these structural elements, which, in turn, are
modulated by phosphorylation and interaction with other
regulatory proteins (Figure 1). A crucial residue involved in c-
Src auto phosphorylation is Tyr165.5 Autophosphorylation of
catalytically inactive kinases can occur, demonstrating that
phosphorylation must proceed in trans.6 SH2 and SH3
domains (residues 151−248 and 84−145, respectively) are
crucial elements substrate recruitment and in the catalytic
activity modulation.7 In physiological condition, the c-Src
enzyme is almost inactive in cells, while dramatic changes in its
activity occur when the fine balance between phosphorylation
and dephosphorylation is altered. However, if the fine balance
between phosphorylation and dephosphorylation is disrupted,
changes can occur in the c-Src activity with drastic results.8,9 c-
Src contains a catalytic loop (residues 385−403) formed by
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Asp and Asn residues that are highly conserved and very
important for the Mg−ATP complex coordination. Residues
404−432 form the activation loop. This region plays a key role
in the kinase activity because it is involved in the
phosphorylation of Tyr416, a protein modification required
for full enzymatic activation. In particular, c-Src lives in “open”
active and “closed” inactive conformations that are structurally
well understood, a behavior similar to other Src family
members.10 In order to bind Mg−ATP and the protein
substrate, the enzyme has to assume the open form. Starting
from this open conformation, the protein starts converting to
the closed one as the catalysis occurs. As the catalysis ends, the
enzyme is reconverted to the open form, the phosphorylated
protein and Mg−ADP are released, and the next catalytic cycle
can occur. The open form of the active enzyme binds Mg−
ATP and the protein substrate; this is accompanied by the
conversion to the closed form as catalysis occurs. After
catalysis, the phosphorylated protein and then Mg−ADP are
released as the enzyme is reconverted to the open form prior to
the next catalytic cycle. The two main phosphorylation sites on
c-Src are represented by Tyr416 and Tyr527. Phosphorylation
of Tyr527 is one of the mechanisms for the regulation of the c-
Src activity. When Tyr527 is phosphorylated, the molecule
adopts a folded, inaccessible bundle, and the inactive
configuration is mediated by an intramolecular interaction
between the phosphorylated Tyr527 and the SH2 domain of c-
Src.11 This “inactive conformation” is stabilized by a network
of interactions between several residues. In particular, Asp404
forms an electrostatic interaction with Lys295, and in this way,
it disrupts the Lys295-Glu310 interaction, which is essential for
the maintenance of the active state. As a consequence of the
Asp404−Lys295 interaction, Phe424 moves toward the α-C-
helix of the c-Src N-lobe, forcing the helix to move away from
the catalytic cleft.12 Moreover, Tyr416 is oriented toward the
catalytic center of the kinase domain when residues 413−418
of the activation loop form a short α-helix (A-loop helix). In
this way, Tyr416 is not only able to form hydrogen bonds with
Arg385 and Asp386 but is also buried into a hydrophobic
cavity in order to be protected from autophosphorylation.13 In
addition, the active conformation of the α-C-helix is stabilized
by the formation of a salt bridge between Glu310 of the α-C-
helix and Arg409.14,15 When Tyr527 becomes dephosphory-
lated, this bond is disrupted, the kinase is opened to an active
state, and the autophosphorylation of the residue Tyr416
occurs. Protein interactions also act to regulate c-Src by either
directly activating c-Src or moving c-Src to the sites of action.16
As such, it results that the complex network of interactions
determining the structural behavior of c-Src suggests a
conformational plasticity intrinsic to this protein family. On
the other hand, the ATP analogs such as tyrophostin and
pyrimidine compounds directly inhibit the tyrosine kinase
activity of c-Src and/or related kinases.17−21 However, the
inhibition of c-Src by means of small molecules remains quite
difficult because of the very likely to generate mechanisms of
resistance such as point mutations in the drug binding site 21.
Therefore, alternative routes to develop selective drugs
represent an invaluable resource. Among others, the
identification of allosteric binding sites able to affect the c-
Src conformational behavior represents an effective strategy
able, in principle, to overcome the drug resistance and
selectivity issues.22 The effectiveness of such a strategy strongly
depends on the knowledge of the structural modifications
occurring between the inactive and the active states of the
kinase. In this way, the complex regulatory networkwhich
dynamically evolves along the transition pathwaycould be
effectively handled to regulate the protein activity. From a
computational point of view, the description of the pathway
although possible in principleis strongly limited by the
process timescale, preventing the effectiveness of computa-
tional techniques such as molecular dynamics (MD).23 To
overcome such a limit, several methods able to enhance the
sampling have been applied to study the kinase conformational
transitions, such as coarse-grained representations and
enhanced sampling techniques.24−26
Recently, an unprecedented computational effort based on
distributed computing has been used to describe the c-Src
activation pathways by means of all-atoms unbiased MD
simulations.27,28 This work has not only been able to map the
c-Src activation conformational transition without the use of
external biases but it also provides an invaluable reference to
measure the effectiveness and the accuracy of different
enhancing sampling techniques.
In this framework, we present here the study of the c-Src
conformational transition pathways by means of the essential
dynamics sampling (EDS), an enhanced sampling technique
able to efficiently sample such slow and wide conformational
rearrangements. The EDS rejects movements (in the
conformational space) not in the desired direction, driving
Figure 1. Comparison of active (PDB ID: 1FMK) and inactive (PDB ID: 2SRC) crystal structures of the c-Src kinase. Coloring from N to C
terminus: the SH3 domain in green, the SH2 domain in blue, the linker connecting the SH2 domain and the N-lobe of the kinase domain in purple,
the kinase domain N-lobe and C-lobe in light brown. The αC helix and A-loop are colored in deep brown and red, respectively.
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the sampling toward a known structure (target). The
advantages of EDS are that (i) no ad hoc terms are introduced
in the Hamiltonian and (ii) the system moves along its own
essential eigenvectors as provided by unbiased MD. Moreover,
the contraction procedure used in this work guaranteesby
constructionthat the system reaches the final state, being
only slightly constrained all along the pathway.29
With respect to other theoretical methods potentially able to
model these kinds of processes (i.e., free-energy methods or
coarse-grained models), it is worth noting that in the EDS
procedure, (i) the model is not biased and thus it is easily
transferable to other systems/processes; (ii) the model does
not require ad hoc parametrization; and (iii) the description is
at the atomistic level. The main limitation of EDS is the
difficulty to estimate the relative weight of the intermediate
conformations sampled along the path.
In this work, the EDS technique has been applied to the
both opening and closing processes of c-Src to provide a
detailed atomistic description of the corresponding pathways,
unrevealing for the first time the differences at the base of such
complex conformational transitions. The EDS trajectories have
been analyzed in detail and compared with the reference
trajectories as obtained by means of massive distributed
computing (m.d.c.).27 The results clearly show that these kinds
of processes can be described by the proposed procedure with
very limited computational efforts and with an accuracy in the
pathway description comparable to unbiased MD simulations.
2. COMPUTATIONAL METHODS
MD simulations were performed on c-Src using the Gromacs
software package version 5.0.5.30 The initial structures were the
c-Src in the closed (inactive state, PDB ID: 2SRC) and open
conformations (active state, PDB ID: 1Y57), respectively. Only
the kinase domains were considered: residues from Ala175 to
Leu449 for 1Y57 and Ala259 to Leu533 for 2SRC. The two
conformational states of the kinase domains were (separately)
solvated in rectangular boxes large enough to contain the
enzyme and 1 nm of the solvent on all sides, resulting in 84
514 atoms and 72 049 atoms for the open and closed forms,
respectively. Sodium ions were added to provide a neutral
simulation cell. During the simulations, the temperatures were
maintained at 300 K using the velocity rescaling algorithm.31
The Amber99sb force field was used.32 For the solvent, the
water SPC model33 was used at a standard density (1 kg/dm3).
The Verlet cutoff scheme was used;34 long-range electrostatic
interactions were treated by means of the particle mesh Ewald
method.35,36 For all simulations, the protein secondary
structures were monitored to ensure that no unfolding
occurred. All the analyses were performed using the Gromacs
tools included in the package, unless otherwise specified. The
first 20 ns of the two trajectories was considered as
equilibration and has been removed from the analysis. In
line with our previous work,37 the principal component
analysis (PCA) was performed using the covariance matrix of
the fluctuations of the C-α motions as obtained by the
combined trajectories of both the conformational states. In this
way, the eigenvectors describe the motion directions
connecting the close and the open forms of c-Src, and they
can be used in the EDS procedure to decrease the distance
from the reference conformation (i.e., the contraction
procedure). In such a procedure, at each time frame, a classic
MD step is performed, and the distance between the current
and the reference conformation in the subspace is calculated.
The step is accepted if the distance decreases. If this does not
occur, the atomic coordinates are projected radially on the
subspace hypersphere centered on the target conformation.
The hypersphere is defined by the set of the essential
eigenvectors of the C-α atoms given by the PCA analysis
performed on the two concatenated (free) MD trajectories.
The displacement in the essential subspace during one time
step of MD can be represented by
ξ ξΔξ = Δ + Δd c
where Δξd is the displacement produced by the MD step and
Δξc is the correction for the application of the constraint. The
constraint in the essential subspace can be defined as
ξ =G t t( ( ); ) 0
To obtain a unique solution to this equation, the
requirement is that the total perturbation |Δξc| is minimized
by adding one Lagrangian multiplier (the mathematical details
can be found in ref 29).
Following our previous work,37 we performed a preliminary
set of EDS simulations varying the number of eigenvectors
used to define the subspace. In this way, we assess the
minimum number of eigenvectors able to describe the
transitions but still leading final structures very similar to
those extracted from the free MD simulations and used as
targets. We found that the use of the first 100 eigenvectors
leads to structures which are still very similar to the
corresponding targets (see Table S1 in the Supporting
Information), providing at the same time a very limited bias
on the trajectory. To select proper reference structures
representative of the two conformational states, a cluster
analysis of the unbiased MD simulations has been performed
[the Gromacs tool g_cluster with the default cutoff value of 0.1
nm on the root-mean-square deviation (rmsd) was used],
providing nine representative structures for both the open and
the closed forms. Every possible structure pair has been then
used as the starting and arrival states in the EDS procedure,
providing 162 (81 × 2) possible paths connecting the two
protein conformational states. A scheme of our approach is
reported in the Supporting Information (Figure S1). These
conformational pathways have been compared to those
obtained by Shukla et al.27 In that study, a m.d.c. approach
was used to reproduce the transition between the closed and
the open forms of c-Src. To this end, the authors employed a
very large number of small trajectories which required a huge
computational effort. In that work, the authors collected about
500 ms of all-atoms unbiased MD trajectories, and ∼20 000
structures have been considered as the representative of the
whole set of MD simulations (freely available from https://
searchworks.stanford.edu/view/cm993jk8755). This represen-
tative trajectory was converted in the “dcd” format to import
and analyze it by means of the “bio3d” package of R software.
To compare our approach with the m.d.c. results, we calculated
for each c-Src structure as sampled by both m.d.c and EDS
approaches, two structural observables (defined in Shukla et
al.27 and we were able to describe the conformational
pathways): (i) the rmsd of the activation loop (A-loop) and
(ii) the distance difference between the two pairs of the
residues (i.e., Glu310 and Lys295). The rmsd was calculated
using the “rmsd” function of the “bio3d” package of R software.
The native contact analysis has been performed considering
the distance between all the C-α atoms of the protein. For any
frame obtained by the EDS, the C-α−C-α distance is
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measured, and the residues pair is considered in contact if their
distance is less than 6 Å.
Two residues are not considered in contact if they have a
sequence distance of less than 4, even if their distance in
structure is less than 6 Å. The first frame of each EDS
trajectory (which represents the protein in the starting
conformation) is considered as the reference structure for
the analysis. For each frame, we defined the fraction of native
contacts (Q) as the ratio between the number of contacts in
common with the reference structure and the number of
contacts for such a frame.
3. RESULTS AND DISCUSSION
To obtain an accurate description of the c-Src kinase domain
in the two reference states (i.e., open and closed), we first
performed a 200 ns long classical MD simulation for both the
active and the inactive forms of c-Src. As expected, the
secondary structure elements as well the overall fold do not
change along the trajectories, and both the proteins remain in
the conformational basin common to the corresponding
starting structure. Following our previous work,37 we apply
the EDS technique using the set of the first 100 eigenvectors
and eigenvalues obtained by the diagonalization of the atomic
fluctuation covariance matrix of the trajectory obtained by
merging the active and the inactive MD simulations (hereafter
called the concatenated trajectory). The resulting first two
eigenvectors obtained by the ED analysis on the concatenated
trajectory represent the 92% of the variance of the whole
protein motion, which includes the open and the closed
conformational basins. As expected, the first eigenvector
characterizing the motion direction linking the two conforma-
tional statesdescribes almost the total motion of the system
(∼87%). By means of a clustering analysis, 18 representative
structures (9 for the “active” form and 9 for the “inactive”
form) have been selected from the two unbiased MD and used
as the starting and target structures for the EDS procedure.
That is, the EDS runs were performed to connect each of the
nine representative structures of the open state with each one
of the nine structures of the closed states (and vice versa). In
this work, the EDS algorithm has been used in the contraction
scheme, that is, to decreasealong the simulationthe
distance in the essential subspace between the selected
reference structure and the target structure. By such an
approach, 81 trajectories from close to open conformations
and 81 trajectories from open to close conformations have
been obtained.
3.1. Activation Pathway Identified through the EDS
Technique. The analysis of the EDS trajectories performed
along the activation pathway reveals that the main changes are
carriedas expectedby the A-loop and the C-helix (see
Figure 2). In particular, in the opening process, the
rearrangements of such regions occur in a concerted fashion:
the A-loop runs outward, whereas the C-helix moves inward, in
completely agreement with previous computational stud-
ies.13,38
Other conformational changes involve residues buried
within the protein domain, Leu325, Met314, Phe405, and
His384. They form a skeleton of four nonconsecutive
hydrophobic residues that constitute a regulatory region,
called R-spine, linking the two lobes of the catalytic domain. It
is critical for the catalytic activity of the kinase because it is
usually broken in the deactivation process.39,40 Our analysis
confirms that this interaction pathway is rapidly broken during
the transition from the active to the inactive form. Our results
also show that His384, Arg385, and Asp386 (called HRD
motif) maintain the same orientation during the opening
process. In the open conformation, the HRD motif does not
interact with the A-loop nor with the C-helix. Only after that
the C-helix has reached the open conformation and the A-loop
moved outward, Arg385 starts to interact with Tyr416
belonging to the A-loop. The electrostatic interactions between
Arg385, Tyr416, Arg409, Glu310, Lys295, and Asp404 are
known to be involved in the conformational changes occurring
during the activation and the deactivation processes.39
Previous studies have shown that in the closed conformation,
there is a peculiar electrostatic interaction network formed by
the following couples: Glu310 with Arg409, Arg385 with
Tyr416, and Lys295 with Asp404. In the open conformation,
these interactions do not take place. Our simulations,
confirming such a behavior (Figure 3A,B), also outline that
in the activation process, the first interaction to be broken is
between Arg385 with Tyr416, anchoring the A-loop to the
HRD motif (Tyr416 moves away so that the A-loop starts to
move outward and, almost simultaneously, the C-helix starts
moving inward). As a result of these motions, the residues
Arg409 (belonging to the A-loop) and Glu310 (in the C-helix)
no longer interact (Figure 3A).
3.2. Deactivation Pathway Identified through the
EDS Technique. In the deactivation process, we found that
the HRD motif interacts with Tyr416. As the A-loop moves
inward, Tyr416 (belonging to the A-loop) starts to interact
with R385 as observed in a previous study of Src kinase
conformational activation.41
During the deactivation process, our simulations show that
the interaction between Tyr416 and Arg409 disappears early;
the A-loop starts to fold, and the C-helix is almost in the closed
conformation. However, the interaction between Lys295 and
Glu310 is still in place. At the same time, the interaction
between Lys295 and Glu310 vanishes. The C-helix is in the
closed conformation and starts to twist and tilt, driving Glu310
outward, where it finally interacts with Arg409. At the end of
the deactivation process, the interactions between Arg385 and
Tyr416 take place, stabilizing the structure in the closed
conformation (Figure 3B).
The closed conformation is stabilized by the interaction
between the A-loop with the HRD motif, the C-helix
interacting with the N-lobe. After the Lys295 and Glu310
Figure 2. Superimposition of active (in blue) and inactive (in gold) c-
Src conformations along the activation pathway obtained by using the
EDS approach. The conformational changes of the αC helix and A-
loop (residues 402−424) reveal outward movements of the A-loop
while the αC-helix moves inward.
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interaction is broken, the A-loop and C-helix show a concerted
movement until the interactions stabilizing the closed
conformation take place.
3.3. Activation Pathway: Comparison between the
EDS and m.d.c Approaches. As highlighted in the
Introduction section, the main goal of the present work has
been the validation of the sampling as obtained by the EDS
technique. To this end, the EDS trajectories were compared to
the recent work of Shukla et al.,27 where the conformational
transition pathways of the c-Src activation process were
described by m.d.c.. In that work, making use of huge
computational resources, the authors performed ∼24 000 MD
simulations totally lasting 50 ms. The results were summarized
in a single trajectory (using an adaptive sampling algorithm
based on the Markov state model approach), which we used to
compare our EDS data.
In the work of Shukla et al.,27 the authors characterized two
intermediate states of the c-Src kinase domain by means of two
simple structural observables: (i) the rmsd of the A-loop with
respect to the inactive state and (ii) the distance between the
two residue pairs (Glu310−Arg409 and Lys295−Glu310).
The comparison between the behaviors of these two
observables in the two different approaches is reported in
Figure 4. We can clearly notice that EDS essentially provides
the same intermediate structures of the unbiased simulations
with respect to these observables (rmsd of the A-loop and the
difference between the Glu310−Arg409 and Lys295−Glu310
distances). In fact, starting from similar (i.e., sampled within
the same conformational basin) closed structures, both the
methods describe the activation process by an initial change in
the A-loop conformation followed by the formation of the
Lys295−Glu310 H-bond and the rupture of the Glu310−
Arg409 one. The differences in the point densities are due to
the fact that the EDS algorithm does not provide the correct
weight of the sampling as the m.d.c does. Very importantly,
such results strongly suggest thatat the orders of magnitude
fasterthe EDS algorithm actually provides the same
intermediates as those sampled by an unbiased m.d.c. approach
(at least in the subspace described by the A-loop rmsd and by
the difference between the Glu310−Arg409 and Lys295−
Glu310 distances).
To further compare the two sampling methodologies, the
EDS and the m.d.c., we projected the two sets (i.e., EDS and
m.d.c.) of structures sampled along the activation pathway on
the subspace spanned by the two principal eigenvectors
(Figure 4). As the eigenvalues correspond to the mean square
eigenvector coordinate fluctuation and, therefore, contain the
contribution of each principal component to the total
fluctuation, the projections have been scaled according to the
ratio between the two eigenvalues (0.057). The projections
along the first principal component as obtained by the EDS
technique reported in Figure 5 closely resemble those provided
by the m.d.c. approach. The discrepancy along the second
principal component, between the EDS and m.d.c. inactive
state (still very small), is due to the different conditions used to
define the productive phase of the corresponding simulations.
In fact, Shukla et al. have reconstructed a unique trajectory
to describe the conformational transitions of the Src kinase
combining several short trajectorieslasting 20 ns plus 1 ns
considered as the equilibration timeinto a single model.27
On the other hand, the nine reference structures used as the
starting point and the nine structures representing the target
(arrival) points of the EDS trajectories were extracted from the
corresponding conformational basins as provided by two single
and independent “free” 200 ns MD runs (note that these 200
ns long MD simulations were only used to describe the two
forms, whereas the paths connecting the two forms have been
modeled by means of EDS). In such two MD simulations, the
first 20 ns was considered as an equilibration phase and hence
discarded from the analysis. Including such 20 ns of sampling
(Figure S2), it is clear that the differences between our
approach and the m.d.c. one is due to such a difference in the
starting points of the pathway. In summary, the presented data
clearly provide evidence that the EDS trajectories describe the
Figure 3. (A,B) Changes in the position and interaction of specific residues (Arg385, Tyr416, Arg409, Glu310, Lys295, and Asp404) accompanying
the large conformational changes during the activation and deactivation processes [(A) open form; (B) closed form].
Figure 4. Two-dimensional conformational landscape of the c-Src
tyrosine kinase with respect to rmsd of A-loop residues (x-axis) and
difference of the distance between the Glu310−Arg409 and Lys259−
Glu310 (y-axis) residue pairs. The changes in the structural
observables provided by the EDS and m.d.c. approaches are
represented as blue and red points, respectively.
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conformational changes on the activation pathway very similar
to those obtained by means of the m.d.c. approach. These
results strongly suggest that our methodology can provide a
reliable sampling along the opening and closing processes
occurring in the c-Src kinase.
3.4. Activation and Deactivation Pathways. Because of
the EDS computational efficiency, the EDS procedure has also
been applied to model the deactivation process. The major
structural observables changing along the process have been
highlighted in the previous section. Nevertheless, additional
information arises when comparing the opening and the
closing pathways. First, the projection of the closing pathways
on the essential subspace indicates no relevant differences with
respect to the c-Src activation within such a subspace (Figure
6). On the contrary, the plot of the distances between Glu310,
Arg409, and Lys295 versus the rmsd of the A-loop as occurring
along the open-to-close pathway (Figure 7) shows some
interesting differences with respect to the activation process
(Figure 4). In fact, although in the opening process the H-
bond network changes follow the A-loop “unfolding” process
(Figure 5), in the closing process, the H-bond network starts
to change quite quickly (Figure 7).
In other words, our data suggest that, differently from the
activation pathway, the open-to-close mechanism might
involve the rupture of the H-bond between Lys295 and
Glu310 in the very first part of the process. The differences
between the two pathways are also confirmed by the C-helix
tilt angle. Considering that the C-helix movement is one of the
major conformational changes involved in the processes, in
Figure 8, we report the probability to have a tilt angle variation
greater than 60° along the paths. That is, we consider that the
A-helix conformational change occurred when the tilt angle
(variation) reaches this value, taking as zero its initial value (for
the sake of clarity, the graphical representations of c-Src
structures at various tilt angle values are given in Figure S3). As
Figure 5. Projection along the first and second principal components
of nine EDS opening trajectories (blue points) connecting the
projections given by the MD of the open and closed states (black
points in left and right regions, respectively). The projections of the
closed and intermediate structures as provided by the m.d.c approach
are represented as gray and red points.
Figure 6. Projection along the first and second principal components
of nine EDS deactivation trajectories (green points) connecting the
projections given by the MD of the open and closed states (black
points in left and right regions, respectively). Projections of the closed
and intermediate structures as provided by the m.d.c approach are
represented as gray and red points.
Figure 7. Changes in the structural observables as provided by the
EDS during the deactivation process. In x-axis is reported the rmsd of
A-loop, whereas in the y-axis is reported the difference between the
two distances: the first and the second distances are related to the
pairs Glu310−Arg409 and Lys295−Glu310, respectively.
Figure 8. The probability to observe the C-helix tilt transition, as
measured by a corresponding tilt angle greater than 60°, vs the
number of the EDS frames for the opening (the blue line and points)
and for the closing (the green line and points) processes.
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shown in Figure S3, the C-helix transition occurs in a wide
interval, indicating that different EDS trajectories employ a
different number of EDS steps to move the C-helix in the final
inactive state.
On the contrary, in almost all the EDS opening trajectories,
the C-helix suddenly reaches its final open conformation. In
Figure S4, we also reported the fraction of conserved native
contact (Q) trajectories along the conformational transitions
for six representative EDS trajectories (three for the activation
process and three for the deactivation process). Interestingly,
both the processes retain a remarkable fraction (between 70
and 80%) of the native contacts of the corresponding starting
forms, indicating that a large part of local contacts is not
influenced by such a large conformational rearrangement. As
expected, the protein regions mainly determining such a native
contact decrease are the C-helix (residues 298−309) and the
A-loop (residues 411−419) ones (see Figure S4).
These results clearly point out the different mechanisms
between the activation and the deactivation processes: in the
former, the H-bond network is maintained (Figure 4), and the
C-helix transition can occur on a wide interval of frames
(Figure 8, blue line), whereas in the deactivation mechanism,
the H-bond (Figure 7) and C-helix changes (Figure 8, green
line) are likely to occur in the very first part of the process. The
described mechanism of activation/inactivation has the
potential to improve the drug selectivity (which is very limited
in the case of conserved binding site), for example, designing
new molecules targeting a low-conserved protein region, which
might affect one specific protein conformational transition
pathway. Therefore, the proposed approach, able to describe
slow processes occurring in large biomolecular systems with
extreme computational efficiencies, seems very well suited for
the design of new inhibitors, acting on different protein regions
as well as to shed new light on complex conformational
equilibria. In addition, it can give insights into the conforma-
tional rearrangements occurring in different processes such as
small ligand binding or transition channel opening.
4. CONCLUSIONS
In this study, we modeled the conformational transitions
occurring along the pathways connecting the active and
inactive states of the c-Src kinase. The complex molecular
rearrangements occurring along the activation pathways are in
line with previous observations based on the unbiased all-
atoms simulations obtained by means of m.d.c..
The active to inactive transition is mainly described by the
C-helix and A-loop rearrangements as well as the dynamical
change of the interactions in important c-Src motifs (R-spine
and HRD motif). Our results clearly show that our approach
provides a similar accuracy with respect to unbiased MD
simulations at the orders of magnitude faster and, very
importantly, without arbitrariness on the choice of the
parameters needed to describe the process.
Because of the EDS computational efficiency and the
agreement of our data with that produced by Shukla et al.27
for the c-Src activation pathway, the deactivation pathway has
also been described. Interestingly, the associated mechanism is
slightly different with respect to the activation: we have found
thatin contrast to the opening pathwaythe C-helix
rearrangement occurs in the very first few EDS steps during
the deactivation and the characteristic H-bond network of the
closed structure involving the residues Lys295, Glu310, and
Arg409.
Finally, we think that the possibility to describe the
molecular pathways connecting the active and inactive states
at reduced computational cost might improve the discovery of
new drugs able to interact with different protein regions and
traps the protein in a specific conformational state as well as to
better understand the effect of point mutations on complex
conformational equilibria.
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